(FTV) Fortive - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US34959J1088
FTV EPS (Earnings per Share)
FTV Revenue
FTV: Test, Measurement, Software, Healthcare
Fortive Corporation is a diversified industrial company that designs, develops, and manufactures a wide range of professional and engineered products, software, and services. The companys business is organized into three main segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions, each serving distinct industries and markets. With a strong presence in the United States, China, and internationally, Fortive leverages its diverse portfolio of brands to deliver innovative solutions that enhance customer productivity, efficiency, and safety.
The Intelligent Operating Solutions segment is a leading provider of advanced instrumentation, software, and services that cater to various industries, including manufacturing, healthcare, and utilities. Through brands like Fluke, Gordian, and Industrial Scientific, this segment offers a broad range of products and services that enable customers to optimize their operations, ensure compliance, and improve worker safety. The segments focus on connected worker safety and compliance solutions is particularly noteworthy, as it addresses a critical need in industries where worker safety is paramount.
The Precision Technologies segment is a key player in the industrial, power and energy, and medical equipment sectors, among others. With brands such as Gems, Setra, and Tektronix, this segment delivers high-quality electrical test and measurement, sensing, and material technologies that are essential for various applications. The segments product portfolio is designed to meet the precise needs of its customers, who require accurate and reliable solutions to drive their businesses forward.
The Advanced Healthcare Solutions segment is a significant provider of critical workflow solutions for the healthcare industry. Through brands like ASP, Censis, and Sterrad, this segment offers a range of products and services that enhance patient care, improve clinical productivity, and ensure the safe sterilization of medical instruments. The segments focus on instrument tracking, biomedical test tools, and radiation detection and safety monitoring is particularly relevant in todays healthcare landscape, where patient safety and quality of care are top priorities.
Analyzing Fortives technical data, we observe that the stock is currently trading at $72.14, with a 20-day SMA of $71.03 and a 50-day SMA of $69.51, indicating a positive short-term trend. The 200-day SMA stands at $74.55, suggesting that the stock is slightly below its long-term average. With an ATR of 1.74, representing a 2.42% daily volatility, the stock has shown a relatively stable price movement. Considering the fundamental data, Fortives market capitalization stands at $24.68 billion, with a P/E ratio of 31.85 and a forward P/E of 18.87, indicating a reasonable valuation. The companys RoE of 7.69% suggests a decent return on equity.
Based on the technical and fundamental data, our forecast suggests that Fortive Corporation is poised for a moderate growth trajectory. With a strong presence in diverse industries and a robust portfolio of brands, the company is well-positioned to capitalize on emerging trends and opportunities. As the stock is currently trading below its 200-day SMA, we anticipate a potential rebound in the near term, driven by the companys solid fundamentals and a favorable industry outlook. Our analysis indicates a potential target price range of $80-$85 in the next 6-12 months, representing a 10-15% upside from current levels.
Additional Sources for FTV Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
FTV Stock Overview
Market Cap in USD | 23,734m |
Sector | Technology |
Industry | Scientific & Technical Instruments |
GiC Sub-Industry | Industrial Machinery & Supplies & Components |
IPO / Inception | 2016-07-01 |
FTV Stock Ratings
Growth Rating | 22.2 |
Fundamental | 29.5 |
Dividend Rating | 51.1 |
Rel. Strength | -14.5 |
Analysts | 3.85 of 5 |
Fair Price Momentum | 62.70 USD |
Fair Price DCF | 53.14 USD |
FTV Dividends
Dividend Yield 12m | 0.44% |
Yield on Cost 5y | 0.58% |
Annual Growth 5y | 5.40% |
Payout Consistency | 98.5% |
Payout Ratio | 8.2% |
FTV Growth Ratios
Growth Correlation 3m | 28.3% |
Growth Correlation 12m | -14.2% |
Growth Correlation 5y | 51.4% |
CAGR 5y | 4.73% |
CAGR/Max DD 5y | 0.15 |
Sharpe Ratio 12m | 0.14 |
Alpha | -16.37 |
Beta | 1.001 |
Volatility | 31.00% |
Current Volume | 2676.9k |
Average Volume 20d | 2833.9k |
As of June 26, 2025, the stock is trading at USD 70.08 with a total of 2,676,922 shares traded.
Over the past week, the price has changed by +0.36%, over one month by -0.99%, over three months by -7.65% and over the past year by -3.54%.
Neither. Based on ValueRay´s Fundamental Analyses, Fortive is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 29.49 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FTV is around 62.70 USD . This means that FTV is currently overvalued and has a potential downside of -10.53%.
Fortive has received a consensus analysts rating of 3.85. Therefor, it is recommend to buy FTV.
- Strong Buy: 6
- Buy: 5
- Hold: 9
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, FTV Fortive will be worth about 71.7 in June 2026. The stock is currently trading at 70.08. This means that the stock has a potential upside of +2.31%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 83.4 | 19% |
Analysts Target Price | 83.4 | 19% |
ValueRay Target Price | 71.7 | 2.3% |